PURCHASE ORDER
Active75F40126P00197
Department of Health and Human Services › Food and Drug Administration › FDA OFFICE OF ACQ GRANT SVCS
$131.3K
obligated · signed 2 months ago
NOVA BIOPROFILE FLEX 2 OPERATIONAL PARTS AND COMPONENTS FOR THREE CURRENTLY OWNED NOVA BIOPROFILE FLEX 2 INSTRUMENTS DUE TO CONTINUING WORK ON UPSTREAM BIOMANUFACTURING RESEARCH.
Performance timeline
Start
Sep 11, 2026
End
Sep 10, 2027
with all options
Loading status
This contract is likely in the recompete window
Ends with all options: Sep 10, 2027
NOVA BIOMEDICAL CORP
Contract 75F40126P00197
UEI
LCFDHTGXB5J3
Parent Company
NOVA BIOMEDICAL CORP
Capabilities & Certifications
Headquarters Location
Congressional District: 05
Current Obligation
$131,322
Base + Exercised Options
$131,322
Total Ceiling Value
$131,322
Contract Type
FIRM FIXED PRICE
NAICS
ANALYTICAL LABORATORY INSTRUMENT MANUFACTURING
PSC
LABORATORY EQUIPMENT AND SUPPLIES
Place of Performance
Congressional District: 04
Awarding Agency
Top-tier agency
Food and Drug Administration
Sub-tier agency
FDA OFFICE OF ACQ GRANT SVCS
Office
Funding Agency
Top-tier agency
Food and Drug Administration
Sub-tier agency
FDA OFFICE OF ACQ GRANT SVCS
Office
Solicitation procedures, competition exceptions, labor standards and account totals.